• Women who perceived greater barriers to their AI treatment were more likely to demonstrate AI nonadherence behaviors by the end of their treatment period compared to those who reported fewer barriers (OR, 1.71).

• Conversely, perceived susceptibility to cancer recurrence and perceived benefits of AIs did not appear to predict AI adherence.